CHOLAFIN.NS vs. ADMA

Last updated Jun 13, 2026

CHOLAFIN.NS (Cholamandalam Investment and Finance Company Limited) and ADMA (ADMA Biologics, Inc.) are both stocks. CHOLAFIN.NS operates in Credit Services (Financial Services), while ADMA operates in Biotechnology (Healthcare). Over the past 10 years, CHOLAFIN.NS returned 28.91%/yr vs 5.39%/yr for ADMA. At a 0.02 correlation, their price movements are largely independent.

Performance

CHOLAFIN.NS vs. ADMA - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Cholamandalam Investment and Finance Company Limited (CHOLAFIN.NS) and ADMA Biologics, Inc. (ADMA). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CHOLAFIN.NS is traded in INR, while ADMA is traded in USD. To make them comparable, the ADMA values have been converted to INR using the latest available exchange rates.

Returns By Period

In the year-to-date period, CHOLAFIN.NS achieves a -7.81% return, which is significantly higher than ADMA's -52.35% return. Over the past 10 years, CHOLAFIN.NS has outperformed ADMA with an annualized return of 28.91%, while ADMA has yielded a comparatively lower 5.39% annualized return.

CHOLAFIN.NS

• 1D: 7.78%
• 1M: -0.41%
• YTD: -7.81%
• 6M: -9.58%
• 1Y: -0.74%
• 3Y*: 12.65%
• 5Y*: 23.02%
• 10Y*: 28.91%

ADMA

• 1D: -1.99%
• 1M: -3.94%
• YTD: -52.35%
• 6M: -56.40%
• 1Y: -57.74%
• 3Y*: 33.38%
• 5Y*: 42.39%
• 10Y*: 5.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CHOLAFIN.NS vs. ADMA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CHOLAFIN.NS Cholamandalam Investment and Finance Company Limited	-7.81%	43.73%	-5.71%	74.66%	39.32%	34.82%	27.18%	34.69%	9.55%	56.84%
ADMA ADMA Biologics, Inc.	-52.35%	11.45%	290.92%	17.30%	204.75%	-26.25%	-50.02%	71.61%	-18.80%	-41.20%

Correlation

The correlation between CHOLAFIN.NS and ADMA is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.11
Correlation (3Y) Calculated over the trailing 3-year period	-0.02
Correlation (5Y) Calculated over the trailing 5-year period	0.01
Correlation (10Y) Calculated over the trailing 10-year period	0.02
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013	0.02

The correlation between CHOLAFIN.NS and ADMA shifts across timeframes, from -0.11 (1 year) to 0.02 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

CHOLAFIN.NS vs. ADMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CHOLAFIN.NS

CHOLAFIN.NS Risk / Return Rank: 40
CHOLAFIN.NS Sharpe Ratio Rank: 42
CHOLAFIN.NS Sortino Ratio Rank: 37
CHOLAFIN.NS Omega Ratio Rank: 36
CHOLAFIN.NS Calmar Ratio Rank: 42
CHOLAFIN.NS Martin Ratio Rank: 41

ADMA

ADMA Risk / Return Rank: 3
ADMA Sharpe Ratio Rank: 3
ADMA Sortino Ratio Rank: 4
ADMA Omega Ratio Rank: 4
ADMA Calmar Ratio Rank: 3
ADMA Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CHOLAFIN.NS vs. ADMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cholamandalam Investment and Finance Company Limited (CHOLAFIN.NS) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CHOLAFIN.NS	ADMA	Difference
Sharpe ratio: Return per unit of total volatility	-0.02	-1.06	+1.04
Sortino ratio: Return per unit of downside risk	0.21	-1.60	+1.81
Omega ratio: Gain probability vs. loss probability	1.02	0.79	+0.24
Calmar ratio: Return relative to maximum drawdown	-0.03	-0.95	+0.92
Martin ratio: Return relative to average drawdown	-0.08	-1.94	+1.86

CHOLAFIN.NS vs. ADMA - Sharpe Ratio Comparison

The current CHOLAFIN.NS Sharpe Ratio is -0.02, which is higher than the ADMA Sharpe Ratio of -1.06. The chart below compares the historical Sharpe Ratios of CHOLAFIN.NS and ADMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CHOLAFIN.NS vs. ADMA - Drawdown Comparison

The maximum CHOLAFIN.NS drawdown since its inception was -80.59%, smaller than the maximum ADMA drawdown of -89.36%. Use the drawdown chart below to compare losses from any high point for CHOLAFIN.NS and ADMA.

Drawdown Indicators

	CHOLAFIN.NS	ADMA	Difference
Max Drawdown Largest peak-to-trough decline	-80.59%	-89.36%	+8.77%
Max Drawdown (1Y) Largest decline over 1 year	-24.91%	-60.62%	+35.71%
Max Drawdown (3Y) Largest decline over 3 years	-28.67%	-65.42%	+36.75%
Max Drawdown (5Y) Largest decline over 5 years	-28.67%	-65.42%	+36.75%
Max Drawdown (10Y) Largest decline over 10 years	-64.28%	-84.33%	+20.05%
Current Drawdown Current decline from peak	-13.08%	-62.70%	+49.62%
Average Drawdown Average peak-to-trough decline	-14.44%	-48.97%	+34.53%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.67%	30.70%	-21.03%

Volatility

CHOLAFIN.NS vs. ADMA - Volatility Comparison

Cholamandalam Investment and Finance Company Limited (CHOLAFIN.NS) has a higher volatility of 11.30% compared to ADMA Biologics, Inc. (ADMA) at 10.16%. This indicates that CHOLAFIN.NS's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CHOLAFIN.NS	ADMA	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.30%	10.16%	+1.14%
Volatility (6M) Calculated over the trailing 6-month period	26.38%	45.45%	-19.07%
Volatility (1Y) Calculated over the trailing 1-year period	32.33%	54.51%	-22.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.98%	58.90%	-24.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.96%	68.83%	-27.87%

Dividends

CHOLAFIN.NS vs. ADMA - Dividend Comparison

CHOLAFIN.NS's dividend yield for the trailing twelve months is around 0.13%, while ADMA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ADMA ADMA Biologics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
CHOLAFIN.NS Cholamandalam Investment and Finance Company Limited	0.13%	0.12%	0.17%	0.16%	0.28%	0.38%	0.18%	8.35%	12.90%	10.58%	11.88%	13.63%

Financials

Frequently Asked Questions

Can I hold both CHOLAFIN.NS and ADMA in my portfolio?

CHOLAFIN.NS and ADMA have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.